Correlation between clinical and histological analyses in retroocular connective tissues and extraocular muscles from patients with graves' ophthalmopathy

Endocrine Pathology

Volumn 11, Issue 2, 2000, Pages 185-194

  Matos, Kimble ^a   Nosé, Vania ^b   Manso, Paulo Gois ^b   Ho, Reinaldo Furlane ^b   Marback, Edwardo ^b   Nakanami, Celia ^b   Nakanami, Deise ^b   Pares, Luis ^b   Stamato, Francisco ^b  

^a MOORFIELDS EYE HOSPITAL   (United Kingdom)

^b NONE

Author keywords

Connective tissue; Extraocular muscles; Graves; Histopathology; Ophthalmopathy

Indexed keywords

COLCHICINE; DICLOFENAC; LEVOTHYROXINE; PREDNISOLONE; PROPRANOLOL; PROPYLTHIOURACIL; THIAMAZOLE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONNECTIVE TISSUE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE CLASSIFICATION; EXTRAOCULAR MUSCLE; EYE DISEASE; FEMALE; GRAVES DISEASE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATORY CELL; MALE; OPHTHALMOLOGY; PRIORITY JOURNAL;

EID: 0033867941     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1385/EP:11:2:185     Document Type: Article

References (35)

1. 1. Heufelder AE. Pathogenesis of Graves' ophthalmopathy: recent controversies and progress. Eur J Endocrinol 132:532-541, 1995.
2. 2. Bahn, RS, Heufelder, AE. Mechanisms of disease; pathogenesis of Graves' ophthalmopathy. N Engl J Med 329:1468-1475, 1993.
3. 3. Burch HB, Wartofsky L. Graves' ophthalmopathy: current concepts regarding pathogenesis and management. Endocr Rev 14:747-793, 1993.
4. 4. Weetman AP. Thyroid associated eye disease: pathophysiology. Lancet. 338:25-32, 1991.
5. 5. German CA, Heufelder AE, Bartley GB. Ophthalmology. In: DeGroot LJ (ed). Endocrinology. Saunders, Philadelphia, PA, 1994, pp. 712-725.
6. 6. Hufnagel TJ, Hickey, WF, Cobbs, WH, Jacobiec, FA, Eagle, RC. Immunohistochemical and ultrastructural studies on the exentered orbital tissues of a patient with Graves' Ophthalmopathy. Ophthalmology 91:1411-1419, 1984.
7. 7. Tallstedt L, Norberg R. Immunohistochemical staining of normal and Graves' extraocular muscle. Invest Ophtalmol Vis Sci 29:175-184, 1988.
8. 8. Heufelder AE, Bahn RS. Elevated expression in situ of selection and immunoglobulin superfamily adhesion molecules in retroocular connective tissues from patients with Graves' Ophthalmopathy. Clin Exp Immunol 91:381-389, 1993.
9. 9. Weetmann AP, Cohen S, Gatter KC, Fells D, Shine B. Immunohistochemical analysis of the retrobulbar tissues in Graves' ophthalmopathy. Clin Exp Immuno. 75:222-227, 1989.
10. 10. Trokel SL, Jacobiec FA, Correlation of CT scanning and pathologic Graves' disease. Ophthalmology 88:553-564, 1981.
11. 11. Campbell RJ. Pathology of Graves' ophthalmopathy. In: Gormann, CA, Waller RA, Dyer JA, (eds.). The eye and the orbit in thyroid disease. Raven Press, New York, 1984; pp. 25-31.
12. 12. Kroll AJ, Kuwabara T. Dysthyroid ocular myopathy; anatomy, histology, and electron microscopy. Arch Ophthalmol 76:244-257, 1966.
13. 13. Scott WE, Thalacker JA. Diagnosis and treatment of thyroid myopathy. Ophthalmology 88:493-498, 1981.
14. 14. Kiljanski JI, Nebes V, Wall JR. The ocular muscle cell is a target of the immune system in endocrine ophthalmology. Int Arch Allergy Immunol 106:204-212, 1995.
15. 15. Riley FC. Orbital pathology in Graves' disease. Mayo Clin Proc 47:975,1972.
16. 16. Wegelius O, Asboe-Hansen G, Lamberg B-A. Retrobulbar connective tissue changes in malignant exophthalmos. Acta Endocrinol (Copenh) 25:452,1957.
17. 17. Mourits MP, Prummel MF, Wiersinga WM, Koornneef L. Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy. Clinical Endocrinology 47:9-14, 1997.
18. 18. Werner SC. Modification of the classification of the eye changes of Graves' disease: Recommendations of the Ad Hoc Committee of the American Thyroid Association. Clin Endocrinol Metab 44:203-204, 1977.
19. 19. Asboe-Hansen G, Iversen K. Influence of thyrotrophic hormone on connective tissue: pathogenetic significance of mucoplysaccharides in experimental exoftalmos. Acta Endocrinol (Kbh) 8:90-96, 1951.
20. 20. Wegelius O, Asboe-Hansen G, Lamberg B-A. Retrobulbar connective tissue changes in malignant exophathalmos. Acta Endocrinol (Kbh) 25:452-456, 1957.
21. 21. Tengroth B. Histological studies of orbital tissues in a case of endocrine exophthalmos before and after remission. Acta Ophthalmo (Kbh) 42:588-591, 1964.
22. 22. Ludwig AW, Boas NF, Soffer LJ. Role of mucopolysaccharides in pathogenesis of experimental exophthalmos. Proc Soc Exp Biol Med 73:137-140, 1950.
23. 23. Smelser GK, Ozanics V. Hydrophilia of the orbital connective tissue in experimental exophthalmos. Am J Ophthalmol 47:380-387, 1959.
24. 24. Smelser GK. A comparative study of experimental and clinical exophthalmos. Am J Ophthalmol 20:1189-1203, 1937.
25. 25. Ossoinig KC. Standardized echography: basic principles clinical applications and results. Int Ophthalmol Clin 19(4):127-210, 1979.
26. 26. Prummel MF, Suttorp-Schulten MSA, Wiersinga WM, Verbeek AM, Mourits MP, Koornneef L. A new ultrasonographic method to detect disease activity and predict response to immunosuppressive treatment in Graves' ophthalmopathy. Ophthalmology 100:556-561, 1993.
27. 27. Marcocci C, Vitti P, Cetani F, et al. Thyroid ultrasonography helps to identify patients with diffuse lymphocytic thyroiditis who are prone to develop hypothyroidism. J Clin Endocrinol Metab 72:209-213, 1991.
28. 28. Skalka HW. The use of ultrasonography in the diagnosis of endocrine orbitopathy. Neuro Ophthalmology 1:109-116, 1980.
29. 29. Harrie RP. A - scan in Graves' ophthalmopathy-letters to editor, Opthalmology, 100:10, 1993.
30. 30. Byrne SF, Gendron EK, Glaser JS, Fever W, Atta HR. Diameter of normal extraocular recti muscles with echography. Am J Ophthalmol 112:706-713, 1991.
31. 31. Bahn RS. The fibroblast is the target cell in the connective tissue manifestations of Graves' disease. Int Arch Allergy Immunol 106:213-218, 1995.
32. 32. Heufelder AE, Bahn RS. Detection and localisation of cytokine immunoreactivity in retroocular connective tissue in Graves' ophthalmopathy. Eur J Clin Invest 23:10-17, 1993.
33. 33. Pappa A, Calder V, Ajjan R, Fells P, Ludgates M, Weetman AP, Lightman S. Analysis of extraocular muscle-infiltrating T cells in thyroid-associated ophthalmopathy (TAO). Clin Exp Immunol 109:362-369, 1997.
34. 34. Perros P, Kendall-Taylor P. The pathogenesis of thyroid-associated ophthalmopathy. J Endocrinol 122:619-624, 1989.
35. 35. Bartley GB, Gorman CA. Diagnostic criteria for Graves' ophthalmopathy. Am J Ophthalmol 119, pp. 6, 792-795, 1995.